Home › Companies › LIGAND PHARMACEUTICALS INC. › 2024-2025
Compiled from SEC Form N-PX filings and LIGAND PHARMACEUTICALS INC.’s Form 8-K, filed 2025-06-09 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore LIGAND PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LIGAND PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-09 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jason M. Aryeh | 13,595,137 | -- | -- | 3,224,879 | 1,363,582 | Majority: yes |
| Elect Director: Todd C. Davis | 16,393,716 | -- | -- | 426,300 | 1,363,582 | Majority: yes |
| Elect Director: Nancy R. Gray, Ph.D. | 16,470,033 | -- | -- | 349,983 | 1,363,582 | Majority: yes |
| Elect Director: Jason Haas | 16,621,292 | -- | -- | 198,724 | 1,363,582 | Majority: yes |
| Elect Director: John W. Kozarich, Ph.D. | 15,684,962 | -- | -- | 1,135,054 | 1,363,582 | Majority: yes |
| Elect Director: John L. LaMattina, Ph.D. | 15,961,637 | -- | -- | 858,379 | 1,363,582 | Majority: yes |
| Elect Director: Stephen L. Sabba, M.D. | 15,789,883 | -- | -- | 1,030,133 | 1,363,582 | Majority: yes |
| Elect Director: Martine Zimmermann, Pharm.D. | 16,666,655 | -- | -- | 153,361 | 1,363,582 | Majority: yes |
| Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved. | 15,576,200 | 1,183,843 | 59,973 | -- | 1,363,582 | Majority: yes |
Source: LIGAND PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2025-06-09 — read the filing on EDGAR.
Each item below shows how the 334 asset managers that disclosed a LIGAND PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LIGAND PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2025-06-06.
Combines 8 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 15,576,200 for, 1,183,843 against, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 81% for, 6% against (87% of the company cast a for/against vote).
The 328 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,398,216 | 1,038 | 0 | 0 | For |
| BlackRock | 2,176,447 | 7,286 | 0 | 0 | For |
| Janus Henderson | 987,087 | 4,185 | 0 | 0 | For |
| State Street | 930,133 | 6,891 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 840,083 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Loomis Sayles | 622,949 | 28,088 | 0 | 0 | For |
| CONGRESS ASSET MANAGEMENT CO | 553,551 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 484,171 | 0 | 0 | 0 | For |
| Dimensional | 481,706 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 426,507 | 0 | 0 | 0 | For |
| Fidelity | 418,550 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| Chicago Capital, LLC | 342,298 | 0 | 0 | 0 | For |
| Charles Schwab | 325,917 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 319,767 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 295,790 | 0 | 0 | Against |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX ASSET MANAGEMENT LLC | 280,208 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| ASHFORD CAPITAL MANAGEMENT INC | 279,072 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Northern Trust | 266,041 | 879 | 0 | 0 | For |
| VILLERE ST DENIS J & CO LLC | 262,870 | 0 | 0 | 0 | For |
Showing the 25 largest of 328 asset managers. See all 328 in the interactive database.
Meeting held 2025-06-06.
Combines 6 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason Haas”): 16,621,292 for, 198,724 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 86% for, 1% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,265,877 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,348,140 | 0 | 0 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,288 | 0 | 0 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,563 | 0 | 0 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 6 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Jason M. Aryeh”): 13,595,137 for, 3,224,879 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 71% for, 17% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (8,764,389 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,347,098 | 0 | 1,042 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 689,703 | 0 | Abstain |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 0 | 18 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 240,684 | 0 | Abstain |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 122,052 | 0 | Abstain |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 0 | 0 | 93,303 | 0 | Abstain |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 26,518 | 0 | 43,609 | 0 | Abstain |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 53,952 | 0 | Abstain |
| Brighthouse | 6,718 | 0 | 44,613 | 0 | Abstain |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 9 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John L. LaMattina, Ph.D.”): 15,961,637 for, 858,379 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 83% for, 4% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,264,512 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,348,139 | 0 | 1 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 0 | 18 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: John W. Kozarich, Ph.D.”): 15,684,962 for, 1,135,054 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 81% for, 6% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,168,361 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,347,102 | 0 | 1,038 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 0 | 18 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 0 | 0 | 93,303 | 0 | Abstain |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Nancy R. Gray, Ph.D.”): 16,470,033 for, 349,983 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 85% for, 2% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,262,774 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,347,103 | 0 | 1,037 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,288 | 0 | 0 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Stephen L. Sabba, M.D.”): 15,789,883 for, 1,030,133 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 82% for, 5% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,171,209 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,348,138 | 0 | 2 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 0 | 18 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 0 | 0 | 93,303 | 0 | Abstain |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Todd C. Davis”): 16,393,716 for, 426,300 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 85% for, 2% withheld (87% of the company cast a for/withheld vote).
The 99 asset managers below cast 100% of the shares they voted on this item FOR (10,251,959 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,348,139 | 0 | 1 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 0 | 18 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,308 | 0 | 255 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Meeting held 2025-06-06.
99.9% fund support · no official result
The 98 asset managers below cast 99.9% of the shares they voted on this item FOR (10,206,850 for, 9,891 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,348,139 | 1 | 0 | 0 | For |
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| State Street | 285,270 | 18 | 0 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,563 | 0 | 0 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.
Meeting held 2025-06-06.
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Martine Zimmermann, Pharm.D.”): 16,666,655 for, 153,361 withheld, per its Form 8-K filed 2025-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 86% for, 0.8% withheld (87% of the company cast a for/withheld vote).
The 78 asset managers below cast 100% of the shares they voted on this item FOR (7,466,667 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,346,569 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 889,850 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 689,703 | 0 | 0 | 0 | For |
| Dimensional | 408,856 | 0 | 0 | 0 | For |
| Fidelity | 405,401 | 0 | 0 | 0 | For |
| State Street | 285,288 | 0 | 0 | 0 | For |
| MFS | 281,879 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 280,208 | 0 | 0 | 0 | For |
| DWS | 276,745 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 160,000 | 0 | 0 | 0 | For |
| Charles Schwab | 153,807 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 122,052 | 0 | 0 | 0 | For |
| Aberdeen | 93,303 | 0 | 0 | 0 | For |
| Allspring | 71,495 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,127 | 0 | 0 | 0 | For |
| Invesco | 60,753 | 0 | 0 | 0 | For |
| Russell Investments | 53,952 | 0 | 0 | 0 | For |
| Brighthouse | 51,331 | 0 | 0 | 0 | For |
| First Trust | 49,348 | 0 | 0 | 0 | For |
| Equitable | 48,835 | 0 | 0 | 0 | For |
| Pacific Life | 46,995 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 46,013 | 0 | 0 | 0 | For |
| TIAA | 43,443 | 0 | 0 | 0 | For |
| American Century | 41,790 | 0 | 0 | 0 | For |
| Northern Trust | 29,970 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Meeting held 2025-06-06.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 25 asset managers below cast 100% of the shares they voted on this item FOR (2,799,210 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,740,918 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 383,338 | 0 | 0 | 0 | For |
| Loomis Sayles | 240,684 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 135,482 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 100,563 | 0 | 0 | 0 | For |
| Calamos | 56,344 | 0 | 0 | 0 | For |
| Jackson National | 37,431 | 0 | 0 | 0 | For |
| AMG FUNDS | 30,517 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 18,407 | 0 | 0 | 0 | For |
| JPMorgan | 18,306 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 10,242 | 0 | 0 | 0 | For |
| John Hancock | 7,472 | 0 | 0 | 0 | For |
| Allianz | 6,750 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 3,313 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 2,960 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 2,597 | 0 | 0 | 0 | For |
| Vanguard | 1,571 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 978 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 864 | 0 | 0 | 0 | For |
| GPS Funds I | 161 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 150 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 76 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 50 | 0 | 0 | 0 | For |
| RBB Fund Trust | 34 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 2 | 0 | 0 | 0 | For |
Meeting held 2025-06-06.
All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB Fund Trust | 7,504 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 6,582 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 5 | 0 | 0 | 0 | For |
Meeting held 2025-06-06.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (14,091 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RBB Fund Trust | 7,504 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 6,582 | 0 | 0 | 0 | For |
| VOISARD ASSET MANAGEMENT GROUP, INC. | 5 | 0 | 0 | 0 | For |
Meeting held 2025-06-06.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (34,938 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GuideStone | 20,305 | 0 | 0 | 0 | For |
| Empower | 14,622 | 0 | 0 | 0 | For |
| UNIFIED SERIES TRUST | 11 | 0 | 0 | 0 | For |
Meeting held 2024-06-14 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
LIGAND PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3 . The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 14,264,205 for, 1,253,085 against, per its Form 8-K filed 2024-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 19,276,000 outstanding shares: 74% for, 7% against (81% of the company cast a for/against vote).
The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 152 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| COLDSTREAM CAPITAL MANAGEMENT INC | 0 | 152 | 0 | 0 | Against |
| Echo45 Advisors LLC | 0 | 0 | 0 | 0 | -- |
Ranked by the number of LIGAND PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 19,276,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.45% |
| 2 | BlackRock | 11.33% |
| 3 | Janus Henderson | 5.14% |
| 4 | State Street | 4.86% |
| 5 | JANUS INVESTMENT FUND | 4.62% |
| 6 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 4.36% |
| 7 | Delaware/Macquarie | 3.58% |
| 8 | Loomis Sayles | 3.38% |
| 9 | CONGRESS ASSET MANAGEMENT CO | 2.87% |
| 10 | Stephens Investment Management Group LLC | 2.51% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Ligand Pharmaceuticals Incorporated | 41.83% | 13D |
| BlackRock | 15.15% | 13F |
| Vanguard Group | 10.66% | 13F |
| Vanguard Portfolio Management | 5.75% | 13G |
| JANUS HENDERSON GROUP PLC | 5.41% | 13G |
| Dimensional Fund Advisors | 3.86% | 13F |
| State Street | 3.77% | 13F |
| Todd C. Davis | 1.63% | DEF14A |
| Matthew Korenberg | 1.58% | DEF14A |
| Northern Trust | 1.52% | 13F |
Percentages above are of 19,276,000 shares outstanding, as reported by LIGAND PHARMACEUTICALS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LIGAND PHARMACEUTICALS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At LIGAND PHARMACEUTICALS INC.'s shareholder meeting held 2025-06-06, in the 2024-2025 proxy season, 334 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,602 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the named executive officers — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LIGAND PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-09.
LIGAND PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.